深度学习用于放射治疗治疗规划的自分化:最先进的技术和新的视角
Ayhan Can Erdur1,2, Daniel Rusche3, Daniel Scholz4,5
1Institute for Artificial Intelligence and Informatics in Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str., 81675, Munich, Bavaria, Germany. can.erdur@tum.de.
概括
人工智能 (AI) 通过自动化风险器官 (OAR) 和瘤体积细分来增强放射治疗计划. 这种人工智能驱动的方法提高了个性化癌症治疗的效率,一致性和精度.
科学领域:
- 辐射瘤学 辐射瘤学
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 人工智能 (AI) 正在迅速发展,影响包括医疗保健在内的各种部门.
- 放射性瘤学越来越多地在患者护理途径中采用人工智能工具.
- 准确细分瘤和有风险的器官 (OARs) 对于有效的放射治疗计划至关重要.
研究的目的:
- 审查当代人工智能技术用于放射治疗规划中的自动化细分.
- 探索人工智能的临床应用,以界定有风险的器官 (OAR),总瘤体积 (GTV) 和临床目标体积 (CTV).
- 评估基于AI的细分工具的效率,一致性和节省时间的好处.
主要方法:
- 审查当前的人工智能技术和细分模型.
- 对商业和免费软件细分工具的分析.
- 基于文献和内部发现的各种临床场景中基于AI的细分的评估.
主要成果:
- 基于人工智能的自动细分证明了放射治疗规划的提高效率和一致性.
- 在不同的临床场景中可以实现显著的时间节省.
- 个性化治疗计划的潜在好处是巨大的,尽管存在诸如领域转移等实施挑战.
结论:
- 由人工智能驱动的自动细分为放射治疗规划提供了显著的优势,提高了精度和个性化.
- 与瘤生长模型和基于人工智能的瘤检测的整合进一步完善了目标体积的划分.
- 综合细分和规划系统的未来前景承诺更快,更精确和个性化的放射治疗治疗.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...


